IDH2 and neoplasm: Loss of NADPH deficiency because of IDH2 mutant activity slows down the conversion of oxidized glutathione (GSSG) to reduced glutathione (GSH), which is a major antioxidant against oxidative stress induced by reactive oxygen species (ROS), and this may lead to ROS accumulation and oxidative DNA damage to promote tumor cell growth23,24.